Armin Ghobadi Selected Research

Biomarkers (Surrogate Marker)

1/2023	A systematic framework for predictive biomarkers in immune effector cell-associated neurotoxicity syndrome.
6/2022	Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma.
1/2021	Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Armin Ghobadi Research Topics

Disease

23	Neoplasms (Cancer) 11/2023 - 01/2017
19	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 12/2017
12	Lymphoma (Lymphomas) 02/2024 - 12/2016
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 01/2019
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 02/2014
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 12/2017
6	Multiple Myeloma 01/2022 - 05/2013
5	Cytokine Release Syndrome 10/2022 - 01/2017
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2023 - 12/2017
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 12/2016
4	Leukemia 01/2022 - 10/2016
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 01/2016
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2023 - 10/2020
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2023 - 01/2017
3	Hematologic Neoplasms (Hematological Malignancy) 11/2022 - 06/2015
3	Residual Neoplasm 01/2021 - 12/2019
3	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020 - 06/2015
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2022
2	cell-associated neurotoxicity 01/2023 - 01/2021
2	Philadelphia Chromosome 11/2022 - 01/2021
2	Infections 12/2017 - 12/2016
1	Synovial Sarcoma (Synovioma) 05/2024
1	Disease Progression 02/2024
1	Rare Diseases (Rare Disease) 01/2024
1	Testicular Neoplasms (Testicular Cancer) 01/2023
1	Central Nervous System Diseases (CNS Diseases) 11/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Bites and Stings (Sting) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Leukocytosis (Pleocytosis) 01/2021
1	Pancreatitis 01/2021
1	Inflammation (Inflammations) 10/2020
1	Body Weight (Weight, Body) 12/2017
1	Smoldering Multiple Myeloma 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 12/2016
1	Fever (Fevers) 12/2016

Drug/Important Bio-Agent (IBA)

22	Chimeric Antigen ReceptorsIBA 04/2024 - 12/2017
20	axicabtagene ciloleucelIBA 04/2024 - 01/2017
5	AntigensIBA 01/2023 - 01/2021
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 12/2016
4	Bendamustine Hydrochloride FDA Link 10/2023 - 05/2020
4	Monoclonal AntibodiesIBA 01/2023 - 01/2019
3	blinatumomabIBA 10/2023 - 12/2019
3	brexucabtagene autoleucelIBA 10/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
3	Rituximab (Mabthera)FDA Link 01/2023 - 10/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2024 - 01/2022
2	HLA-A Antigens (HLA-A)IBA 01/2023 - 01/2022
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 11/2022 - 12/2020
2	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 10/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 10/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020 - 12/2017
2	tisagenlecleucelIBA 11/2019 - 01/2019
2	Bortezomib (Velcade)FDA Link 10/2019 - 01/2019
2	Decitabine FDA Link 12/2017 - 11/2016
1	AcidsIBA 05/2024
1	acalabrutinibIBA 01/2023
1	InterferonsIBA 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	Vincristine (Oncovin)FDA LinkGeneric 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	Peptides (Polypeptides)IBA 01/2022
1	CytokinesIBA 01/2022
1	ALT-803IBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	plerixafor FDA Link 01/2021
1	Calcineurin InhibitorsIBA 12/2020
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2020
1	PENTAIBA 05/2020
1	Prednisone (Sone)FDA LinkGeneric 05/2020
1	Cladribine FDA LinkGeneric 01/2020
1	ruxolitinibIBA 01/2020
1	selinexorIBA 01/2020
1	Filgrastim (Neupogen)FDA Link 01/2020
1	liposomal doxorubicin (Doxil)FDA Link 01/2019
1	1-dodecylpyridoxal (PLD)IBA 01/2019
1	AnthracyclinesIBA 01/2019
1	carfilzomibIBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2019
1	alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA 01/2018
1	fludarabineIBA 12/2017
1	Melphalan (Alkeran)FDA LinkGeneric 12/2016

Therapy/Procedure

32	Therapeutics 05/2024 - 05/2013
11	Stem Cell Transplantation 10/2023 - 06/2015
9	Drug Therapy (Chemotherapy) 07/2023 - 01/2016
6	Immunotherapy 01/2023 - 01/2019
6	Cell Transplantation 11/2022 - 05/2013
4	Organ Transplantation 01/2023 - 01/2017
4	Transplantation 12/2020 - 01/2019
2	Aftercare (After-Treatment) 01/2023 - 01/2020
2	Salvage Therapy 05/2020 - 12/2019
1	Radiotherapy 11/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021
1	Hematopoietic Stem Cell Mobilization 10/2019
1	BEAM regimen 12/2016